Authors:
PAPSIN BC
VELLODI A
BAILEY CM
RATCLIFFE PC
LEIGHTON SEJ
Citation: Bc. Papsin et al., OTOLOGIC AND LARYNGOLOGIC MANIFESTATIONS OF MUCOPOLYSACCHARIDOSES AFTER BONE-MARROW TRANSPLANTATION, Otolaryngology and head and neck surgery, 118(1), 1998, pp. 30-36
Authors:
THOMPSON DA
KRISS A
TAYLOR D
RUSSELLEGGITT I
HODGKINS P
MORGAN G
VELLODI A
GERRITSEN EJA
Citation: Da. Thompson et al., EARLY VEP AND ERG EVIDENCE OF VISUAL DYSFUNCTION IN AUTOSOMAL RECESSIVE OSTEOPETROSIS, Neuropediatrics, 29(3), 1998, pp. 137-144
Authors:
SEQUEIRA JSS
VELLODI A
VANIER MT
CLAYTON PT
Citation: Jss. Sequeira et al., NIEMANN-PICK DISEASE TYPE-C AND DEFECTIVE PEROXISOMAL BETA-OXIDATION OF BRANCHED-CHAIN SUBSTRATES, Journal of inherited metabolic disease, 21(2), 1998, pp. 149-154
Authors:
BEESLEY GE
YOUNG EP
VELLODI A
WINCHESTER BG
Citation: Ge. Beesley et al., IDENTIFICATION OF 12 NOVEL MUTATIONS IN THE ALPHA-N-ACETYLGLUCOSAMINIDASE GENE IN 14 PATIENTS WITH SANFILIPPO-SYNDROME TYPE-B (MUCOPOLYSACCHARIDOSIS TYPE-IIIB), Journal of Medical Genetics, 35(11), 1998, pp. 910-914
Authors:
HADDAD FS
JONES DHA
VELLODI A
KANE N
PITT MC
Citation: Fs. Haddad et al., CARPAL-TUNNEL SYNDROME IN THE MUCOPOLYSACCHARIDOSES AND MUCOLIPIDOSES, Journal of bone and joint surgery. British volume, 79B(4), 1997, pp. 576-582
Authors:
YOUNG E
CHATTERTON C
VELLODI A
WINCHESTER B
Citation: E. Young et al., PLASMA CHITOTRIOSIDASE ACTIVITY IN GAUCHER-DISEASE PATIENTS WHO HAVE BEEN TREATED EITHER BY BONE-MARROW TRANSPLANTATION OR BY ENZYME REPLACEMENT THERAPY WITH ALGLUCERASE, Journal of inherited metabolic disease, 20(4), 1997, pp. 595-602
Authors:
VELLODI A
YOUNG EP
COOPER A
WRAITH JE
WINCHESTER B
MEANEY C
RAMASWAMI U
WILL A
Citation: A. Vellodi et al., BONE-MARROW TRANSPLANTATION FOR MUCOPOLYSACCHARIDOSIS TYPE-I - EXPERIENCE OF 2 BRITISH CENTERS, Archives of Disease in Childhood, 76(2), 1997, pp. 92-99
Authors:
RAMASWAMI U
VANTHOFF W
CLAYTON P
VELLODI A
Citation: U. Ramaswami et al., SANFILIPPO DISEASE (MUCOPOLYSACCHARIDOSIS TYPE-III) PRESENTING AS TRANSIENT RENAL TUBULAR DYSFUNCTION, Journal of inherited metabolic disease, 19(1), 1996, pp. 87-88
Authors:
JABADO N
LEDEIST F
CANT A
DEGRAEFFMEEDERS ER
FASTH A
MORGAN G
VELLODI A
HALE G
BUJAN W
THOMAS C
CAVAZZANACALVO M
WIJDENES J
FISCHER A
Citation: N. Jabado et al., BONE-MARROW TRANSPLANTATION FROM GENETICALLY HLA-NONIDENTICAL DONORS IN CHILDREN WITH FATAL INHERITED DISORDERS EXCLUDING SEVERE COMBINED IMMUNODEFICIENCIES - USE OF 2 MONOCLONAL-ANTIBODIES TO PREVENT GRAFT-REJECTION, Pediatrics, 98(3), 1996, pp. 420-428
Authors:
HUANG Y
BRON AJ
MEEK KM
VELLODI A
MCDONALD B
Citation: Y. Huang et al., ULTRASTRUCTURAL-STUDY OF THE CORNEA IN A BONE MARROW-TRANSPLANTED HURLER-SYNDROME PATIENT, Experimental Eye Research, 62(4), 1996, pp. 377-387
Citation: Bd. Lake et al., BONE-MARROW TRANSPLANTATION IN BATTEN-DISEASE (NEURONAL CEROID-LIPOFUSCINOSIS) - WILL IT WORK - PRELIMINARY STUDIES ON COCULTURE EXPERIMENTS AND ON BONE-MARROW TRANSPLANT IN LATE INFANTILE BATTEN-DISEASE, American journal of medical genetics, 57(2), 1995, pp. 369-373
Citation: Ma. Gatzoulis et al., CARDIAC INVOLVEMENT IN MUCOPOLYSACCHARIDOSES - EFFECTS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION, Archives of Disease in Childhood, 73(3), 1995, pp. 259-260
Authors:
VELLODI A
PICTON S
DOWNIE CJC
ELTUMI M
STEVENS R
EVANS DIK
Citation: A. Vellodi et al., BONE-MARROW TRANSPLANTATION FOR THALASSEMIA - EXPERIENCE OF 2 BRITISHCENTERS, Bone marrow transplantation, 13(5), 1994, pp. 559-562
Authors:
GERRITSEN EJA
VOSSEN JM
FASTH A
FRIEDRICH W
MORGAN G
PADMOS A
VELLODI A
PORRAS O
OMEARA A
PORTA F
BORDIGONI P
CANT A
HERMANS J
GRISCELLI C
FISCHER A
Citation: Eja. Gerritsen et al., BONE-MARROW TRANSPLANTATION FOR AUTOSOMAL RECESSIVE OSTEOPETROSIS - AREPORT FROM THE WORKING PARTY ON INBORN-ERRORS OF THE EUROPEAN BONE-MARROW TRANSPLANTATION GROUP, The Journal of pediatrics, 125(6), 1994, pp. 896-902
Authors:
FISCHER A
LANDAIS P
FRIEDRICH W
GERRITSEN B
FASTH A
PORTA F
VELLODI A
BENKERROU M
JAIS JP
CAVAZZANACALVO M
SOUILLET G
BORDIGONI P
MORGAN G
VANDIJKEN P
VOSSEN J
LOCATELLI F
DIBARTOLOMEO P
Citation: A. Fischer et al., BONE-MARROW TRANSPLANTATION (BMT) IN EUROPE FOR PRIMARY IMMUNODEFICIENCIES OTHER THAN SEVERE COMBINED IMMUNODEFICIENCY - A REPORT FROM THE EUROPEAN GROUP FOR BMT AND THE EUROPEAN GROUP FOR IMMUNODEFICIENCY, Blood, 83(4), 1994, pp. 1149-1154
Authors:
HOPWOOD JJ
VELLODI A
SCOTT HS
MORRIS CP
LITJENS T
CLEMENTS PR
BROOKS DA
COOPER A
WRAITH JE
Citation: Jj. Hopwood et al., LONG-TERM CLINICAL-PROGRESS IN BONE-MARROW TRANSPLANTED MUCOPOLYSACCHARIDOSIS TYPE-I PATIENTS WITH A DEFINED GENOTYPE, Journal of inherited metabolic disease, 16(6), 1993, pp. 1024-1033